Compare HAS & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAS | PEN |
|---|---|---|
| Founded | 1923 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 10.9B |
| IPO Year | N/A | 2015 |
| Metric | HAS | PEN |
|---|---|---|
| Price | $79.83 | $287.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 16 |
| Target Price | $88.55 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 1.7M | 451.4K |
| Earning Date | 10-23-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | N/A | ★ 4.14 |
| Revenue | ★ $4,357,000,000.00 | $1,333,798,000.00 |
| Revenue This Year | $10.26 | $16.77 |
| Revenue Next Year | $6.23 | $14.12 |
| P/E Ratio | ★ N/A | $70.14 |
| Revenue Growth | 0.79 | ★ 14.61 |
| 52 Week Low | $49.00 | $221.26 |
| 52 Week High | $83.45 | $310.00 |
| Indicator | HAS | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.77 | 55.03 |
| Support Level | $81.24 | $284.95 |
| Resistance Level | $82.78 | $303.00 |
| Average True Range (ATR) | 1.86 | 8.78 |
| MACD | -0.08 | -0.94 |
| Stochastic Oscillator | 58.19 | 39.54 |
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.